Joseph Roscoe: Clinical Trials

1 trial sponsored by Joseph Roscoe, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Joseph Roscoe: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial
aprepitant, dexamethasone, granisetron hydrochloride - Nausea
Phase 3CompletedJoseph Roscoe10212006-12-012015-11-10

Conditions studied

Breast Neoplasms (1)  ·  Breast Neoplasms, Male (1)  ·  Inflammatory Breast Neoplasms (1)  ·  Nausea (1)  ·  Vomiting (1)

Interventions

Aprepitant (1)  ·  Calcium Dobesilate (1)  ·  Dexamethasone (1)  ·  Granisetron (1)  ·  Palonosetron (1)  ·  Prochlorperazine (1)

Countries

United States (1)

Top investigators

Joseph A. Roscoe, PhD (1)

Results publications

PMID 22915657

NIH funding

U10CA037420 (1)